and elevation of the preprocedural CRP level in patients undergoing PCI was shown to be associated with the incidence of adverse cardiac events, such as: in-stent restenosis, especially for whose with obesity and diabetes [13–17]. This evidence concerns the gene CRP and diabetes mellitus.